Non-small Cell Lung Cancer Recurrent

Oncology

Prevalence

75.0 / 100K

Incidence

47.0 / 100K/yr

0 drugs in development·0 companies·2 clinical trials

Frequently asked questions

How many clinical trials target Non-small Cell Lung Cancer Recurrent?

There are 2 clinical trials targeting Non-small Cell Lung Cancer Recurrent tracked by BioSniper.

What is the prevalence of Non-small Cell Lung Cancer Recurrent?

The estimated prevalence of Non-small Cell Lung Cancer Recurrent is approximately 75.0 per 100,000 population.

Deep-dive into Non-small Cell Lung Cancer Recurrent

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Non-small Cell Lung Cancer Recurrent — Drugs in Development & Clinical Trials | BioSniper